AAX Biotech Takes Home the Nordic Star Pitch Competition at NLSDays 2026

AAX Biotech Takes Home the Nordic Star Pitch Competition at NLSDays 2026

AAX Biotech was selected as the winner of the ๐—ก๐—ผ๐—ฟ๐—ฑ๐—ถ๐—ฐ ๐—ฆ๐˜๐—ฎ๐—ฟ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ ๐—ฃ๐—ถ๐˜๐—ฐ๐—ต ๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐—ผ๐—ป ๐—ช๐—ถ๐—ป๐—ป๐—ฒ๐—ฟ at NLSDays 2026, held in Stockholm on September 8โ€“9 2026.

Our CEO/CSO Daniel X. Johansson pitched in a field of 13 other Nordic SMEs that represent the cutting edge of life science, from groundbreaking medical devices to life-saving therapeutics.

In the end, Daniel convinced the jury of seasoned investors of AAX Biotechโ€™s technologies, Opti-mAbยฎ and Seqitopeยฎ, and their market potential.

The jury awarded the prize to AAX Biotech for โ€œa highly sophisticated, high impact solution with a clear business caseโ€.

You can read more on the Nordic Star Pitch Competition and NLSDays in their press release.

Next
Next

AAX Biotech Enters Next Phase of Collaboration with Daiichi Sankyo Following Initial Evaluation of Opti-mAbยฎ Technology